We work closely with physicians in North America, Australia & New Zealand to ensure our products are not only safe and effective, but fit-for-purpose and easy to use.
Combining one of the largest known databases of skin lesions and next-generation technology, we're desiging products with patient safety at the heart of what we do.
Next-generation A.I. technology
Our clinical program and medical advisory board have a robust clinical roadmap to ensure our technologies are proven as safe and effective.
Kāhu A.I. technology is being developed in collaboration with Molemap Ltd, to help Doctors discover and diagnose skin cancer.
Support healthcare professionals